好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2025 Annual Meeting | H133 - Lessons Learned from Multi-center Trial Submissions (Research Hub)

Monday 04/07/25
03:00 PM - 03:30 PM PDT Add To Calendar
San Diego Convention Center | 11B
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Hubs (Research)
Gregory S. Day, MD, MSc, FAAN
好色先生, Research, and Methodology, General Neurology
Submitting a multi-center trial grant can be both time consuming and confusing. This session will offer practical tips and solutions for trial submission based on the presenter's personal experience developing, opening, and conducting the NIH-funded ExTINGUISH Trial for NMDAR encephalitis.
No CME available

Program Materials Program Evaluations

Event Timeline
03:00 PM - 03:30 PM PDT Speaker Lessons Learned from Multi-center Trial Submission
Gregory S. Day, MD, MSc, FAAN
Faculty Disclosures
Gregory S. Day, MD, MSc, FAAN Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Parabon Nanolabs. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from Chan Zuckerberg Initiative. The institution of Dr. Day has received research support from Alzheimer's Association. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with 好色先生. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing 好色先生, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.